JUST RELEASED - Transplantation - February 2025 Issue
TRANSPLANTATION - FEBRUARY 2025 ISSUE
The February issue offers a broad update on critical issues of transplantation around the World: Transplantation continues in Ukraine - Reflections and Future Directions shaping the Banff meeting - a comprehensive update on biomarkers and a reality check on xenotransplantation are among the exciting news and evolving science in the field.
CLICK HERE TO ACCESS THIS ISSUE
TTS MEMBERS - CLICK HERE TO SIGN-IN FOR OPEN ACCESS THROUGH TTS.ORG
Abstract Submission for WTC 2025 - Feb 19 Deadline
The World Transplant Congress (WTC) 2025 invites the global transplant community to harness their global collective intelligence to address the challenges of end-organ transplantation.
Submission Deadline: February 19, 2025.
Upcoming Webinar Presentations
Transplantation Journal Highlights
Transplantation Journal - Social Media Content
A Risk Score Using a Cell-based Assay Predicts Long-term Over-immunosuppression Events in Kidney Transplant Recipients
Infections and cancer are major causes of premature death in organ recipients. However, there have been few advances in personalized immunosuppressive therapy. We previously reported that a cell-based assay measuring CD14+16+tumor necrosis factor-α+ monocytes after peripheral blood mononuclear cell (PBMC) incubation with Epstein-Barr virus peptides has a high sensitivity for detecting over-immunosuppression (OIS) events in kidney recipients in the short term. We aimed to develop a risk score for predicting long-term events.
Proteomics in Acute Heart Transplant Rejection, On Behalf of the GRAfT Investigators
Proteomic phenotyping can provide insights into rejection pathophysiology, novel biomarkers, and therapeutic targets.
Transplantation Direct - Social Media Content
Balanced Electrolyte Solutions Versus 0.9% Saline for Kidney Transplantation: An Updated Systematic Review and Meta-analysis
Perioperative intravenous fluids are administered to kidney transplant recipients to maintain hemodynamic stability and graft perfusion; however, the ideal fluid remains uncertain. Although 0.9% saline (saline) is commonly used, its high chloride content causes hyperchloremic metabolic acidosis and may increase the risks of delayed graft function (DGF) and hyperkalemia. Balanced electrolyte solutions (BES) have a more physiological chloride concentration and may reduce these risks. Previous meta-analyses found insufficient evidence to compare BES with saline for these outcomes; however, new studies have recently been published. In this updated review, we compared the effects of BES with saline on the risk of DGF and hyperkalemia in kidney transplantation.
Clinical Outcomes and Donor-specific Antibody Rebound 5 y After Kidney Transplant Enabled by Imlifidase Desensitization
Imlifidase is an IgG-cleaving endopeptidase conditionally approved in Europe for desensitization of highly sensitized patients before kidney transplantation. We present 5-y outcomes and donor-specific antibody (DSA) levels for clinical trial participants from a single site who received imlifidase for desensitization before incompatible transplantation (NCT02790437).
Membership Renewals
Membership renewal notices for TTS and Section Members were sent out December 6th. If you are a member please log into your account to pay your dues and update your profile.
SPLIT 2025 Abstract Submission Deadline - Feb 5, 2025
TTS Scientific Congress Awards
TTS will be supporting the meeting by providing Scientific Congress awards for TTS Members to participate. The awards are designed to help offset expenses incurred to attend meetings and are awarded based on the scientific merit of applicants.
To be eligible you must submit an abstract AND be an eligible TTS Member. Eligible members are trainees/fellows/PhD students, Allied Health Professionals (nurses, psychologist, pharmacist, nutritionist, etc) or Residents of a Lower to Middle Income Country (LMIC).
SPLIT is also offering awards:
- SPLIT-TTS Travel Grants for Trainees, Junior Faculty, and Multi-disciplinary Team Members
- Albireo, an Ipsen Company, and Mirum Travel Grants for Medical Students, Pediatrics Residents, Surgery Residents and Pediatric Gastroenterology fellows identifying as Underrepresented in Medicine
Learn more about awards and abstract submission
Addressing Rare Diseases Using Liver Transplantation
Contribute to the program by submitting your abstract to this year’s SPLIT Annual Meeting. The top four abstracts will receive a travel award and have the opportunity to give a 10 min oral presentation during the meeting. Poster presenters will be able to discuss their work with attendees during our “Welcome Reception & Poster Session”.
IPTA 2025 - Call for Abstracts and Awards Application
Award Opportunities
Awards Application Deadline: APRIL 25, 2025
Abstract presenters who are either trainees, allied health professionals or participants from LMIC regions, are encouraged to apply for one of the IPTA / IPTA-TTS or IPTA-ESOT Congress Awards.
IXA 2025 - Call for Abstracts - Submission Deadline - May 1, 2025
IPITA 2025
19th Congress of the International Pancreas and Islet Transplant Association
ISUTx 2025
5th State-of-the-Art Meeting of the International Society of Uterus Transplantation
Contact
Address
The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada